Trials / Completed
CompletedNCT03599830
Study of the Cognition of Patients Treated With Immunotherapy
Study of the Cognition of Patients Treated With
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Centre Francois Baclesse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigator's longitudinal pilot study aims to evaluate for the first time the impact of immunotherapy on cognition in oncology. Due to the recent nature of immunotherapy, its side effects and impact on quality of life are still poorly understood and, to date, there is no published study evaluating the impact of immunotherapy on cognition in patients treated for cancer. The study consists of the passation of 3 neuropsychological assessments over a period of 6 months in cancer patients who start immunotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cognitive test passations | Tests : MoCA2 Hopkins verbal learning test WAIS-IV Trail Making test Stroop Verbal fluences |
Timeline
- Start date
- 2018-07-10
- Primary completion
- 2023-01-31
- Completion
- 2023-01-31
- First posted
- 2018-07-26
- Last updated
- 2024-02-09
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03599830. Inclusion in this directory is not an endorsement.